nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Methionine—MTHFR—prostate cancer	0.436	1	CbGaD
L-Methionine—BHMT—prostate gland—prostate cancer	0.00731	0.0387	CbGeAlD
L-Methionine—BHMT2—renal system—prostate cancer	0.00678	0.0359	CbGeAlD
L-Methionine—MARS2—prostate gland—prostate cancer	0.00615	0.0326	CbGeAlD
L-Methionine—BHMT—renal system—prostate cancer	0.00498	0.0264	CbGeAlD
L-Methionine—BHMT—urethra—prostate cancer	0.00489	0.0259	CbGeAlD
L-Methionine—MSRA—prostate gland—prostate cancer	0.00461	0.0244	CbGeAlD
L-Methionine—MAT2B—prostate gland—prostate cancer	0.00437	0.0231	CbGeAlD
L-Methionine—MSRB2—prostate gland—prostate cancer	0.0043	0.0228	CbGeAlD
L-Methionine—MSRB1—prostate gland—prostate cancer	0.00423	0.0224	CbGeAlD
L-Methionine—MARS—prostate gland—prostate cancer	0.0041	0.0217	CbGeAlD
L-Methionine—MAT1A—testis—prostate cancer	0.00391	0.0207	CbGeAlD
L-Methionine—MAT2B—seminal vesicle—prostate cancer	0.0037	0.0196	CbGeAlD
L-Methionine—MSRB2—seminal vesicle—prostate cancer	0.00363	0.0193	CbGeAlD
L-Methionine—MSRB1—seminal vesicle—prostate cancer	0.00358	0.0189	CbGeAlD
L-Methionine—MARS—seminal vesicle—prostate cancer	0.00347	0.0184	CbGeAlD
L-Methionine—MSRA—renal system—prostate cancer	0.00315	0.0167	CbGeAlD
L-Methionine—METAP2—prostate gland—prostate cancer	0.00307	0.0162	CbGeAlD
L-Methionine—MSRB2—renal system—prostate cancer	0.00293	0.0155	CbGeAlD
L-Methionine—MAT2A—prostate gland—prostate cancer	0.00293	0.0155	CbGeAlD
L-Methionine—MAT2B—urethra—prostate cancer	0.00293	0.0155	CbGeAlD
L-Methionine—MSRB1—renal system—prostate cancer	0.00288	0.0153	CbGeAlD
L-Methionine—MSRB2—urethra—prostate cancer	0.00288	0.0152	CbGeAlD
L-Methionine—MSRB1—urethra—prostate cancer	0.00283	0.015	CbGeAlD
L-Methionine—MARS—renal system—prostate cancer	0.0028	0.0148	CbGeAlD
L-Methionine—MARS—urethra—prostate cancer	0.00275	0.0146	CbGeAlD
L-Methionine—MARS2—testis—prostate cancer	0.00271	0.0143	CbGeAlD
L-Methionine—MTRR—prostate gland—prostate cancer	0.00266	0.0141	CbGeAlD
L-Methionine—METAP2—seminal vesicle—prostate cancer	0.00259	0.0137	CbGeAlD
L-Methionine—MSRA—bone marrow—prostate cancer	0.00238	0.0126	CbGeAlD
L-Methionine—MTR—prostate gland—prostate cancer	0.00232	0.0123	CbGeAlD
L-Methionine—MTRR—seminal vesicle—prostate cancer	0.00225	0.0119	CbGeAlD
L-Methionine—MAT2B—bone marrow—prostate cancer	0.00225	0.0119	CbGeAlD
L-Methionine—MSRB2—bone marrow—prostate cancer	0.00221	0.0117	CbGeAlD
L-Methionine—MSRB1—bone marrow—prostate cancer	0.00218	0.0115	CbGeAlD
L-Methionine—MARS—bone marrow—prostate cancer	0.00211	0.0112	CbGeAlD
L-Methionine—GLUL—prostate gland—prostate cancer	0.0021	0.0111	CbGeAlD
L-Methionine—METAP2—renal system—prostate cancer	0.00209	0.0111	CbGeAlD
L-Methionine—METAP2—urethra—prostate cancer	0.00205	0.0109	CbGeAlD
L-Methionine—MTHFR—prostate gland—prostate cancer	0.00204	0.0108	CbGeAlD
L-Methionine—MSRA—testis—prostate cancer	0.00203	0.0108	CbGeAlD
L-Methionine—MAT2A—renal system—prostate cancer	0.00199	0.0106	CbGeAlD
L-Methionine—MTR—seminal vesicle—prostate cancer	0.00196	0.0104	CbGeAlD
L-Methionine—MARS2—lymph node—prostate cancer	0.00196	0.0104	CbGeAlD
L-Methionine—MAT2A—urethra—prostate cancer	0.00196	0.0104	CbGeAlD
L-Methionine—MAT2B—testis—prostate cancer	0.00192	0.0102	CbGeAlD
L-Methionine—MSRB2—testis—prostate cancer	0.00189	0.01	CbGeAlD
L-Methionine—MSRB1—testis—prostate cancer	0.00186	0.00987	CbGeAlD
L-Methionine—MTRR—renal system—prostate cancer	0.00182	0.00962	CbGeAlD
L-Methionine—MARS—testis—prostate cancer	0.00181	0.00957	CbGeAlD
L-Methionine—L-Lysine—SLC7A1—prostate cancer	0.0018	0.173	CrCbGaD
L-Methionine—MTRR—urethra—prostate cancer	0.00178	0.00945	CbGeAlD
L-Methionine—L-Cysteine—CSAD—prostate cancer	0.00175	0.168	CrCbGaD
L-Methionine—L-Arginine—SLC7A1—prostate cancer	0.0017	0.164	CrCbGaD
L-Methionine—SLC16A10—prostate gland—prostate cancer	0.0016	0.0085	CbGeAlD
L-Methionine—MTR—renal system—prostate cancer	0.00158	0.00839	CbGeAlD
L-Methionine—METAP2—bone marrow—prostate cancer	0.00158	0.00837	CbGeAlD
L-Methionine—MTR—urethra—prostate cancer	0.00156	0.00824	CbGeAlD
L-Methionine—GLUL—epithelium—prostate cancer	0.00155	0.00819	CbGeAlD
L-Methionine—MAT2A—Fulvestrant—Estradiol—prostate cancer	0.00153	0.274	CbGdCrCtD
L-Methionine—MAT2A—bone marrow—prostate cancer	0.00151	0.00799	CbGeAlD
L-Methionine—MSRA—lymph node—prostate cancer	0.00147	0.00781	CbGeAlD
L-Methionine—GLUL—renal system—prostate cancer	0.00143	0.0076	CbGeAlD
L-Methionine—GLUL—urethra—prostate cancer	0.00141	0.00746	CbGeAlD
L-Methionine—MAT2B—lymph node—prostate cancer	0.0014	0.00739	CbGeAlD
L-Methionine—MTRR—bone marrow—prostate cancer	0.00137	0.00727	CbGeAlD
L-Methionine—MSRB2—lymph node—prostate cancer	0.00137	0.00727	CbGeAlD
L-Methionine—L-Ornithine—SLC7A1—prostate cancer	0.00136	0.131	CrCbGaD
L-Methionine—METAP2—testis—prostate cancer	0.00135	0.00715	CbGeAlD
L-Methionine—MSRB1—lymph node—prostate cancer	0.00135	0.00715	CbGeAlD
L-Methionine—MARS—lymph node—prostate cancer	0.00131	0.00694	CbGeAlD
L-Methionine—MAT2A—testis—prostate cancer	0.00129	0.00683	CbGeAlD
L-Methionine—MTR—bone marrow—prostate cancer	0.0012	0.00634	CbGeAlD
L-Methionine—SLC16A10—epithelium—prostate cancer	0.00118	0.00625	CbGeAlD
L-Methionine—MTRR—testis—prostate cancer	0.00117	0.00622	CbGeAlD
L-Methionine—L-Glutamine—QARS—prostate cancer	0.00114	0.11	CrCbGaD
L-Methionine—GLUL—bone marrow—prostate cancer	0.00108	0.00574	CbGeAlD
L-Methionine—L-Arginine—ARG2—prostate cancer	0.00105	0.101	CrCbGaD
L-Methionine—MTR—testis—prostate cancer	0.00102	0.00542	CbGeAlD
L-Methionine—METAP2—lymph node—prostate cancer	0.000979	0.00518	CbGeAlD
L-Methionine—MAT2A—lymph node—prostate cancer	0.000935	0.00495	CbGeAlD
L-Methionine—GLUL—testis—prostate cancer	0.000927	0.00491	CbGeAlD
L-Methionine—MTHFR—testis—prostate cancer	0.000899	0.00476	CbGeAlD
L-Methionine—MTRR—lymph node—prostate cancer	0.000851	0.00451	CbGeAlD
L-Methionine—L-Ornithine—ARG2—prostate cancer	0.000841	0.0809	CrCbGaD
L-Methionine—MTR—lymph node—prostate cancer	0.000742	0.00393	CbGeAlD
L-Methionine—SLC16A10—testis—prostate cancer	0.000707	0.00374	CbGeAlD
L-Methionine—MAT2A—Daunorubicin—Epirubicin—prostate cancer	0.000702	0.126	CbGdCrCtD
L-Methionine—MAT2A—Doxorubicin—Epirubicin—prostate cancer	0.000702	0.126	CbGdCrCtD
L-Methionine—MAT2A—Idarubicin—Epirubicin—prostate cancer	0.000702	0.126	CbGdCrCtD
L-Methionine—GLUL—lymph node—prostate cancer	0.000672	0.00356	CbGeAlD
L-Methionine—MTHFR—lymph node—prostate cancer	0.000652	0.00345	CbGeAlD
L-Methionine—MAT2A—Epirubicin—Doxorubicin—prostate cancer	0.00065	0.116	CbGdCrCtD
L-Methionine—MAT2A—Idarubicin—Doxorubicin—prostate cancer	0.00065	0.116	CbGdCrCtD
L-Methionine—MAT2A—Daunorubicin—Doxorubicin—prostate cancer	0.00065	0.116	CbGdCrCtD
L-Methionine—SLC16A10—lymph node—prostate cancer	0.000512	0.00271	CbGeAlD
L-Methionine—L-Arginine—NOS3—prostate cancer	0.000403	0.0388	CrCbGaD
L-Methionine—L-Citrulline—NOS3—prostate cancer	0.000343	0.033	CrCbGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CD—prostate cancer	1.12e-05	3.1e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—SRC—prostate cancer	1.11e-05	3.1e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CG—prostate cancer	1.11e-05	3.08e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—CAV1—prostate cancer	1.1e-05	3.07e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—SLC5A5—prostate cancer	1.1e-05	3.07e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—SERPINE1—prostate cancer	1.1e-05	3.07e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—NOS3—prostate cancer	1.1e-05	3.06e-05	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PTEN—prostate cancer	1.1e-05	3.06e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—ERBB3—prostate cancer	1.1e-05	3.05e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—FGFR2—prostate cancer	1.1e-05	3.05e-05	CbGpPWpGaD
L-Methionine—SLC16A10—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.09e-05	3.04e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—COMT—prostate cancer	1.09e-05	3.04e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—GSTP1—prostate cancer	1.09e-05	3.02e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—APC—prostate cancer	1.09e-05	3.02e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—MTHFR—prostate cancer	1.08e-05	3.01e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CYP2E1—prostate cancer	1.08e-05	3e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—STAT3—prostate cancer	1.07e-05	2.99e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—IRS1—prostate cancer	1.07e-05	2.99e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—EGF—prostate cancer	1.07e-05	2.99e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—ITPR1—prostate cancer	1.07e-05	2.97e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—FGF2—prostate cancer	1.07e-05	2.97e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—NQO1—prostate cancer	1.07e-05	2.97e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PPARA—prostate cancer	1.06e-05	2.95e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—TGFBR2—prostate cancer	1.06e-05	2.95e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—NOS3—prostate cancer	1.05e-05	2.93e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—MTHFR—prostate cancer	1.05e-05	2.93e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—TH—prostate cancer	1.05e-05	2.92e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—TERT—prostate cancer	1.05e-05	2.92e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—INS—prostate cancer	1.05e-05	2.92e-05	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—EP300—prostate cancer	1.05e-05	2.92e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—ITPR1—prostate cancer	1.05e-05	2.91e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—GSK3B—prostate cancer	1.04e-05	2.9e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CYP3A4—prostate cancer	1.04e-05	2.89e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—INS—prostate cancer	1.03e-05	2.86e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—CREBBP—prostate cancer	1.03e-05	2.86e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—JAK2—prostate cancer	1.02e-05	2.85e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CYP1B1—prostate cancer	1.02e-05	2.84e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PIK3CB—prostate cancer	1.02e-05	2.83e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—TYMS—prostate cancer	1.01e-05	2.81e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PTGS2—prostate cancer	1.01e-05	2.8e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—CREBBP—prostate cancer	1.01e-05	2.8e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CG—prostate cancer	1.01e-05	2.8e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—HIF1A—prostate cancer	1.01e-05	2.8e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MDM2—prostate cancer	1e-05	2.78e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—CAV1—prostate cancer	9.99e-06	2.78e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—GSTM1—prostate cancer	9.99e-06	2.78e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—MYC—prostate cancer	9.98e-06	2.78e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—TGFB1—prostate cancer	9.96e-06	2.77e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—GGT1—prostate cancer	9.91e-06	2.75e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—ERBB2—prostate cancer	9.86e-06	2.74e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—LPL—prostate cancer	9.81e-06	2.73e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—EGFR—prostate cancer	9.76e-06	2.71e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—NCOA1—prostate cancer	9.76e-06	2.71e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CD—prostate cancer	9.74e-06	2.71e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CB—prostate cancer	9.73e-06	2.71e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—CAV1—prostate cancer	9.73e-06	2.7e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CYP19A1—prostate cancer	9.62e-06	2.67e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—MAP2K1—prostate cancer	9.62e-06	2.67e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—LPL—prostate cancer	9.58e-06	2.66e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—PIK3CD—prostate cancer	9.55e-06	2.66e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—INS—prostate cancer	9.53e-06	2.65e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PDGFRB—prostate cancer	9.5e-06	2.64e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—CYP1A1—prostate cancer	9.47e-06	2.63e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—SERPINE1—prostate cancer	9.45e-06	2.63e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—ERCC2—prostate cancer	9.39e-06	2.61e-05	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—PIK3CA—prostate cancer	9.36e-06	2.6e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CXCL8—prostate cancer	9.35e-06	2.6e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—CREBBP—prostate cancer	9.33e-06	2.59e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—RXRA—prostate cancer	9.28e-06	2.58e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—KRAS—prostate cancer	9.22e-06	2.56e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—NOS3—prostate cancer	9.2e-06	2.56e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—ERCC2—prostate cancer	9.18e-06	2.55e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—BAD—prostate cancer	9.15e-06	2.54e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—FGF2—prostate cancer	9.15e-06	2.54e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CDKN1B—prostate cancer	9.13e-06	2.54e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CG—prostate cancer	9.1e-06	2.53e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—NOS3—prostate cancer	9.02e-06	2.51e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—ERBB3—prostate cancer	8.98e-06	2.5e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—FGFR2—prostate cancer	8.96e-06	2.49e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CASP3—prostate cancer	8.95e-06	2.49e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—COMT—prostate cancer	8.94e-06	2.49e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—IL2—prostate cancer	8.94e-06	2.49e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—GSTP1—prostate cancer	8.9e-06	2.47e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—APC—prostate cancer	8.86e-06	2.46e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CD—prostate cancer	8.85e-06	2.46e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—MTHFR—prostate cancer	8.83e-06	2.46e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PTEN—prostate cancer	8.79e-06	2.44e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—JAK2—prostate cancer	8.77e-06	2.44e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—EGF—prostate cancer	8.76e-06	2.43e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—IRS1—prostate cancer	8.76e-06	2.43e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—ITPR1—prostate cancer	8.76e-06	2.43e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CCND1—prostate cancer	8.71e-06	2.42e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PPARA—prostate cancer	8.66e-06	2.41e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CTNNB1—prostate cancer	8.63e-06	2.4e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—INS—prostate cancer	8.61e-06	2.4e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—TERT—prostate cancer	8.61e-06	2.39e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—MDM2—prostate cancer	8.56e-06	2.38e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—GSK3B—prostate cancer	8.5e-06	2.36e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CB—prostate cancer	8.49e-06	2.36e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—PIK3CA—prostate cancer	8.47e-06	2.36e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MMP9—prostate cancer	8.46e-06	2.35e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—CREBBP—prostate cancer	8.44e-06	2.35e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—ERBB2—prostate cancer	8.44e-06	2.35e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CDKN1A—prostate cancer	8.43e-06	2.34e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PTGS2—prostate cancer	8.41e-06	2.34e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PTEN—prostate cancer	8.41e-06	2.34e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—INS—prostate cancer	8.39e-06	2.33e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—EP300—prostate cancer	8.38e-06	2.33e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—NOS3—prostate cancer	8.35e-06	2.32e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—PIK3CB—prostate cancer	8.33e-06	2.32e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—TYMS—prostate cancer	8.27e-06	2.3e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—PTGS2—prostate cancer	8.25e-06	2.29e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—HIF1A—prostate cancer	8.23e-06	2.29e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—CREBBP—prostate cancer	8.21e-06	2.28e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—GSTM1—prostate cancer	8.18e-06	2.27e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—CAV1—prostate cancer	8.14e-06	2.26e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—LPL—prostate cancer	8.03e-06	2.23e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—EP300—prostate cancer	8.02e-06	2.23e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CD—prostate cancer	8e-06	2.22e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CAV1—prostate cancer	7.96e-06	2.21e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—MAP2K1—prostate cancer	7.84e-06	2.18e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—CDKN1B—prostate cancer	7.81e-06	2.17e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—SRC—prostate cancer	7.8e-06	2.17e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—PIK3CD—prostate cancer	7.79e-06	2.17e-05	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PIK3CA—prostate cancer	7.76e-06	2.16e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CYP1A1—prostate cancer	7.75e-06	2.16e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CB—prostate cancer	7.71e-06	2.14e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—SERPINE1—prostate cancer	7.7e-06	2.14e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—ERCC2—prostate cancer	7.69e-06	2.14e-05	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—AKT1—prostate cancer	7.65e-06	2.13e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PTGS2—prostate cancer	7.64e-06	2.12e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—VEGFA—prostate cancer	7.6e-06	2.11e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—NOS3—prostate cancer	7.55e-06	2.1e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—STAT3—prostate cancer	7.52e-06	2.09e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—IL6—prostate cancer	7.5e-06	2.09e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—BAD—prostate cancer	7.49e-06	2.08e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—FGF2—prostate cancer	7.46e-06	2.07e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CG—prostate cancer	7.42e-06	2.06e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—CTNNB1—prostate cancer	7.38e-06	2.05e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—NOS3—prostate cancer	7.35e-06	2.04e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PTEN—prostate cancer	7.34e-06	2.04e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—APC—prostate cancer	7.25e-06	2.02e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—CDKN1A—prostate cancer	7.21e-06	2.01e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—PTEN—prostate cancer	7.2e-06	2e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—EGF—prostate cancer	7.17e-06	1.99e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—IRS1—prostate cancer	7.17e-06	1.99e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—JAK2—prostate cancer	7.15e-06	1.99e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PPARA—prostate cancer	7.09e-06	1.97e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—INS—prostate cancer	7.02e-06	1.95e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—EP300—prostate cancer	7e-06	1.95e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MYC—prostate cancer	6.99e-06	1.94e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—MDM2—prostate cancer	6.98e-06	1.94e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CB—prostate cancer	6.97e-06	1.94e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—TGFB1—prostate cancer	6.97e-06	1.94e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—GSK3B—prostate cancer	6.96e-06	1.93e-05	CbGpPWpGaD
L-Methionine—METAP2—Disease—AKT1—prostate cancer	6.92e-06	1.92e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PTGS2—prostate cancer	6.91e-06	1.92e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—CREBBP—prostate cancer	6.88e-06	1.91e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—ERBB2—prostate cancer	6.88e-06	1.91e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—INS—prostate cancer	6.86e-06	1.91e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—EP300—prostate cancer	6.86e-06	1.91e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—EGFR—prostate cancer	6.84e-06	1.9e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—PIK3CB—prostate cancer	6.79e-06	1.89e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—PTGS2—prostate cancer	6.73e-06	1.87e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CREBBP—prostate cancer	6.72e-06	1.87e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—SRC—prostate cancer	6.67e-06	1.86e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CAV1—prostate cancer	6.67e-06	1.85e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PTEN—prostate cancer	6.66e-06	1.85e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CD—prostate cancer	6.52e-06	1.81e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—KRAS—prostate cancer	6.46e-06	1.8e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—STAT3—prostate cancer	6.43e-06	1.79e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MAP2K1—prostate cancer	6.42e-06	1.78e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PIK3CD—prostate cancer	6.37e-06	1.77e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—CDKN1B—prostate cancer	6.37e-06	1.77e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—EP300—prostate cancer	6.35e-06	1.77e-05	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—AKT1—prostate cancer	6.34e-06	1.76e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—SERPINE1—prostate cancer	6.3e-06	1.75e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PIK3CA—prostate cancer	6.2e-06	1.72e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—NOS3—prostate cancer	6.16e-06	1.71e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—FGF2—prostate cancer	6.1e-06	1.7e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CG—prostate cancer	6.07e-06	1.69e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PTEN—prostate cancer	6.03e-06	1.68e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—NOS3—prostate cancer	6.02e-06	1.67e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—CTNNB1—prostate cancer	6.02e-06	1.67e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—MYC—prostate cancer	5.98e-06	1.66e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—TGFB1—prostate cancer	5.96e-06	1.66e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CA—prostate cancer	5.93e-06	1.65e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—CDKN1A—prostate cancer	5.88e-06	1.63e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—PTEN—prostate cancer	5.87e-06	1.63e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—JAK2—prostate cancer	5.85e-06	1.63e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—EGFR—prostate cancer	5.85e-06	1.63e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—INS—prostate cancer	5.75e-06	1.6e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—EP300—prostate cancer	5.75e-06	1.6e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—TP53—prostate cancer	5.74e-06	1.6e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MDM2—prostate cancer	5.71e-06	1.59e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CB—prostate cancer	5.68e-06	1.58e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PTGS2—prostate cancer	5.63e-06	1.57e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CREBBP—prostate cancer	5.63e-06	1.57e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—ERBB2—prostate cancer	5.63e-06	1.57e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—EP300—prostate cancer	5.59e-06	1.56e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PIK3CB—prostate cancer	5.56e-06	1.54e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—KRAS—prostate cancer	5.52e-06	1.54e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PTGS2—prostate cancer	5.5e-06	1.53e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—SRC—prostate cancer	5.44e-06	1.51e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CD—prostate cancer	5.34e-06	1.48e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—IL6—prostate cancer	5.25e-06	1.46e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—STAT3—prostate cancer	5.25e-06	1.46e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CDKN1B—prostate cancer	5.21e-06	1.45e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CA—prostate cancer	5.18e-06	1.44e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—PIK3CA—prostate cancer	5.08e-06	1.41e-05	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—AKT1—prostate cancer	5.07e-06	1.41e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—NOS3—prostate cancer	5.04e-06	1.4e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CTNNB1—prostate cancer	4.93e-06	1.37e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PTEN—prostate cancer	4.91e-06	1.37e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—MYC—prostate cancer	4.87e-06	1.36e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—TGFB1—prostate cancer	4.86e-06	1.35e-05	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—AKT1—prostate cancer	4.85e-06	1.35e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CDKN1A—prostate cancer	4.81e-06	1.34e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PTEN—prostate cancer	4.8e-06	1.33e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—EGFR—prostate cancer	4.77e-06	1.33e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CA—prostate cancer	4.7e-06	1.31e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—EP300—prostate cancer	4.68e-06	1.3e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CB—prostate cancer	4.65e-06	1.29e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PTGS2—prostate cancer	4.61e-06	1.28e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—EP300—prostate cancer	4.58e-06	1.27e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—KRAS—prostate cancer	4.5e-06	1.25e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—IL6—prostate cancer	4.49e-06	1.25e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—SRC—prostate cancer	4.45e-06	1.24e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—STAT3—prostate cancer	4.29e-06	1.19e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CA—prostate cancer	4.25e-06	1.18e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—AKT1—prostate cancer	4.23e-06	1.18e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—AKT1—prostate cancer	4.15e-06	1.15e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—PIK3CA—prostate cancer	4.14e-06	1.15e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PTEN—prostate cancer	4.02e-06	1.12e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MYC—prostate cancer	3.99e-06	1.11e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—TGFB1—prostate cancer	3.98e-06	1.11e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—EGFR—prostate cancer	3.9e-06	1.08e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—AKT1—prostate cancer	3.84e-06	1.07e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—EP300—prostate cancer	3.83e-06	1.07e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—KRAS—prostate cancer	3.69e-06	1.02e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—IL6—prostate cancer	3.66e-06	1.02e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—AKT1—prostate cancer	3.47e-06	9.66e-06	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CA—prostate cancer	3.47e-06	9.64e-06	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PIK3CA—prostate cancer	3.39e-06	9.42e-06	CbGpPWpGaD
L-Methionine—MTR—Disease—AKT1—prostate cancer	3.38e-06	9.4e-06	CbGpPWpGaD
L-Methionine—MTHFR—Disease—IL6—prostate cancer	3e-06	8.34e-06	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CA—prostate cancer	2.84e-06	7.89e-06	CbGpPWpGaD
L-Methionine—MTR—Metabolism—AKT1—prostate cancer	2.83e-06	7.87e-06	CbGpPWpGaD
L-Methionine—MTHFR—Disease—AKT1—prostate cancer	2.77e-06	7.69e-06	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—AKT1—prostate cancer	2.32e-06	6.44e-06	CbGpPWpGaD
